Primer: Zai Lab (9688 HK) - Apr 2026
Zai Lab operates on a differentiated 'in-licensing' model, acquiring and commercializing promising drug candidates from global partners for the...
124 Views
𝛼SK or SearchENTITY
Zai Lab (9688 HK)
Zai Lab (9688 HK)
48
Analysis
Health Care • China
Zai Lab is an innovative, research-based, commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products for oncology, immunology, neuroscience, and infectious diseases. The company has commercialized products such as Zejula, Optune, Qinlock, Nuzyra, and Vyvgart in China. Zai Lab was founded in 2014 and is headquartered in Shanghai, China, and Cambridge, Massachusetts, USA.
morex